ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings
ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 第五届董事会第三十七次会议决议公告 | 2024-01-10 | Chinese | |
| 关于选举董事长、聘任首席执行官（CEO）暨调整董事会专门委员会成员的公告 | 2024-01-10 | Chinese | |
| 2020年年度报告（更新后） | 2024-01-04 | Chinese | |
| 关于对广东证监局警示函整改报告的公告 | 2024-01-04 | Chinese | |
| 2021年年度报告（更新后） | 2024-01-04 | Chinese | |
| 关于董事、首席执行官（CEO）辞职及补选非独立董事的公告 | 2023-12-29 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
5 filings
| |||||
| 36040414 | 第五届董事会第三十七次会议决议公告 | 2024-01-10 | Chinese | ||
| 36040406 | 关于选举董事长、聘任首席执行官（CEO）暨调整董事会专门委员会成员的公告 | 2024-01-10 | Chinese | ||
| 36040399 | 2020年年度报告（更新后） | 2024-01-04 | Chinese | ||
| 36040290 | 关于对广东证监局警示函整改报告的公告 | 2024-01-04 | Chinese | ||
| 36040276 | 2021年年度报告（更新后） | 2024-01-04 | Chinese | ||
|
2023
10 filings
| |||||
| 36040193 | 关于董事、首席执行官（CEO）辞职及补选非独立董事的公告 | 2023-12-29 | Chinese | ||
| 36040187 | 关于2024年第一次临时股东大会增加临时提案暨股东大会补充通知的公告 | 2023-12-29 | Chinese | ||
| 36040176 | 第五届董事会第三十六次会议决议公告 | 2023-12-29 | Chinese | ||
| 36040168 | 关于持股5%以上股东及其一致行动人减持股份计划的预披露公告 | 2023-12-29 | Chinese | ||
| 36040160 | 关于召开2024年第一次临时股东大会的通知 | 2023-12-25 | Chinese | ||
| 36040150 | 关于补选非独立董事的公告 | 2023-12-25 | Chinese | ||
| 36040141 | 第五届董事会第三十五次会议决议公告 | 2023-12-25 | Chinese | ||
| 36040131 | 关于收到广东证监局警示函的公告 | 2023-12-22 | Chinese | ||
| 36040121 | 关于控股股东在同一控制下协议转让部分公司股份终止的公告 | 2023-12-08 | Chinese | ||
| 36040107 | 第五届董事会第三十四次会议决议公告 | 2023-12-01 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
ChemPartner PharmaTech Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55161/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55161 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55161 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55161 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55161}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ChemPartner PharmaTech Co., Ltd. (id: 55161)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.